MF
BIOTU

Magnetar Financial’s Biotech Acquisition Company Unit BIOTU Stock Holding History

Magnetar Financial’s Portfolio BIOTU Stock Details BIOTU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-442,393
Closed -$4.45M – 1623
2021
Q3 		$4.45M Hold
442,393
– – 0.05% 407
2021
Q2 		$4.47K Buy
442,393
+4,500
+1% +$45.1K 0.04% 408
2021
Q1 		$4.33M Buy
+437,893
New +$4.5M 0.04% 380

Other funds holding BIOTU

HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
SMA
Sage Mountain Advisors Atlanta, Georgia $1.43B AUM 16.47% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return
WC
Wealthspring Capital West Harrison, New York $448M AUM 8.38% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
SIA
Schechter Investment Advisors Birmingham, Michigan $1.21B AUM 8.73% 1-Year Est. Return
BCM
BCK Capital Management Stamford, Connecticut $23M AUM 33.03% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

Magnetar Financial's BIOTU Position: Q4 2021 in Review

Magnetar Financial sold out of Biotech Acquisition Company Unit (BIOTU) in Q4 2021, closing a stake of 442,393 shares — an estimated $4.45M sold.

Magnetar Financial first reported a position in BIOTU in Q1 2021 and held it in 3 quarters. The position peaked at $4.45M in Q3 2021. 15 funds tracked by Wall St. Rank hold BIOTU as of Q4 2021.

  • Magnetar Financial reported no remaining Biotech Acquisition Company Unit position as of Q4 2021 after selling out during the quarter.
  • Magnetar Financial sold 442,393 Biotech Acquisition Company Unit shares in Q4 2021, an estimated $4.45M.
  • Magnetar Financial first reported a position in Biotech Acquisition Company Unit in Q1 2021 and held it in 3 quarters.
  • Magnetar Financial's Biotech Acquisition Company Unit position peaked at $4.45M in Q3 2021.
  • 15 funds tracked by Wall St. Rank held Biotech Acquisition Company Unit as of Q4 2021.

Based on Magnetar Financial's 13F filing for Q4 2021, filed 14 Feb 2022.